{
    "name": "cyclosporine ophthalmic",
    "comment": "Rx",
    "other_names": [
        "Restasis",
        "Cequa",
        "Verkazia"
    ],
    "classes": [
        "Ophthalmics",
        "Other",
        "Calcineurin Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/cequa-restasis-cyclosporine-ophthalmic-343637",
    "pregnancy": {
        "common": [
            "There are no adequate and well-controlled studies of administration in pregnant females to inform a drug-associated risk"
        ],
        "specific": [
            {
                "type": "Infertility",
                "description": [
                    "No data are available on drug effects on human fertility",
                    "No impairment of fertility reported in animals receiving intravenous cyclosporine"
                ]
            },
            {
                "type": "Animal data",
                "description": [
                    "Oral administration of cyclosporine to pregnant rats or rabbits did not produce teratogenicity at clinically relevant doses ",
                    "Oral administration of cyclosporine oral solution (USP) to pregnant rats or rabbits was teratogenic at maternally toxic doses of 30 mg/kg/day in rats and 100 mg/kg/day in rabbits, as indicated by increased pre- and postnatal mortality, reduced fetal weight and skeletal retardations; doses (normalized to body weight) were ~320 times higher than the daily maximum recommended human ophthalmic dose of 0.015 mg/kg/day"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There is no information regarding drug presence in human milk following topical administration or on effects on breastfed infants and milk production",
            "Administration of oral cyclosporine to rats during lactation did not produce adverse effects in offspring at clinically relevant doses"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Known or suspected hypersensitivity to any of the ingredients in the formulation"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Remove contact lenses prior to administration",
                "Do not touch eyelids with vial tip to avoid contamination",
                "Do not use with contact lenses; lenses may be reinserted 15 minutes following administration ophthalmic emulsion/solution",
                "Patients with decreased tear production typically should not wear contact lenses"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Eye pain",
            "percent": "12"
        },
        {
            "name": "Conjunctival hyperemia Discharge Epiphora Eye pain Foreign body sensation Stinging Visual disturbance",
            "percent": "1-5"
        },
        {
            "name": "eg",
            "percent": "8"
        },
        {
            "name": "blurring",
            "percent": "6"
        },
        {
            "name": "Conjunctival hyperemia",
            "percent": "5"
        },
        {
            "name": "Discharge",
            "percent": "5"
        },
        {
            "name": "Epiphora",
            "percent": "4"
        },
        {
            "name": "Eye pain",
            "percent": "4"
        },
        {
            "name": "Foreign body sensation",
            "percent": "2"
        },
        {
            "name": "Stinging",
            "percent": null
        },
        {
            "name": "Visual disturbance",
            "percent": null
        },
        {
            "name": "eg",
            "percent": null
        },
        {
            "name": "blurring",
            "percent": null
        },
        {
            "name": "Eye pruritus",
            "percent": null
        },
        {
            "name": "Ocular discomfort",
            "percent": null
        },
        {
            "name": "Visual acuity reduced",
            "percent": null
        },
        {
            "name": "Cough",
            "percent": null
        },
        {
            "name": "Ocular hyperemia",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Upper respiratory tract infection",
            "percent": null
        }
    ]
}